Related Experiment Videos
Spitz nevi display allelic deletions.
1Department of Dermatology, University Hospital Zurich, Gloriastr 31, 8091 Zurich, Switzerland.
Archives of Dermatology
|November 16, 2001
Summary
Loss of heterozygosity (LOH) and microsatellite instability (MSI) analysis in Spitz nevi did not differentiate these benign lesions from malignant melanoma. These genetic markers are not suitable for distinguishing between Spitz nevi and melanoma.
Area of Science:
- Dermatology
- Oncology
- Genetics
Background:
- Spitz nevi are benign melanocytic lesions common in children and adolescents.
- Histologically, Spitz nevi can resemble malignant melanoma, posing diagnostic challenges.
- Previous studies have sought diagnostic criteria to differentiate these lesions.
Purpose of the Study:
- To investigate allelic deletions in Spitz nevi.
- To determine if loss of heterozygosity (LOH) or microsatellite instability (MSI) can differentiate Spitz nevi from malignant melanoma.
Main Methods:
- Microdissection of 5 Spitz nevi lesions.
- Evaluation of LOH and MSI at chromosomes 6q, 9p21, 10q, and 14q using specific DNA markers.
- Analysis of genetic alterations in relation to lesion type.
Main Results:
- All lesions showed LOH or MSI with at least one marker.
- No LOH was observed at chromosome 14q.
- LOH and MSI were detected across various markers on chromosomes 6q, 9p21, and 10q.
Conclusions:
- Spitz nevi exhibit LOH and MSI patterns similar to those found in melanoma.
- Analysis of LOH or MSI using the studied markers is not a reliable diagnostic tool for differentiating Spitz nevi from melanoma.